Reduced retention of Pittsburgh compound B in white matter lesions.

TitleReduced retention of Pittsburgh compound B in white matter lesions.
Publication TypeJournal Article
Year of Publication2015
AuthorsGlodzik L, Rusinek H, Li J, Zhou C, Tsui W, Mosconi L, Li Y, Osorio R, Williams S, Randall C, Spector N, McHugh P, Murray J, Pirraglia E, Vallabhajolusa S, de Leon M
JournalEur J Nucl Med Mol Imaging
Volume42
Issue1
Pagination97-102
Date Published2015 Jan
ISSN1619-7089
KeywordsAged, Aniline Compounds, Brain, Female, Humans, Magnetic Resonance Imaging, Male, Middle Aged, Plaque, Amyloid, Positron-Emission Tomography, Radiopharmaceuticals, Thiazoles, White Matter
Abstract

PURPOSE: One of the interesting features of the amyloid tracer Pittsburgh compound B (PiB) is that it generates a signal in the white matter (WM) in both healthy subjects and cognitively impaired individuals. This characteristic gave rise to the possibility that PiB could be used to trace WM pathology. In a group of cognitively healthy elderly we examined PiB retention in normal-appearing WM (NAWM) and WM lesions (WML), one of the most common brain pathologies in aging.

METHODS: We segmented WML and NAWM on fluid attenuation inversion recovery (FLAIR) images of 73 subjects (age 61.9 ± 10.0, 71 % women). PiB PET images were corrected for partial volume effects and coregistered to FLAIR images and WM masks. WML and NAWM PiB signals were then extracted.

RESULTS: PiB retention in WML was lower than in NAWM (p < 0.001, 14.6 % reduction). This was true both for periventricular WML (p < 0.001, 17.8 % reduction) and deep WML (p = 0.001, 7.5 % reduction).

CONCLUSION: PiB binding in WM is influenced by the presence of WML, which lower the signal. Our findings add to the growing evidence that PiB can depict WM pathology and should prompt further investigations into PiB binding targets in WM.

DOI10.1007/s00259-014-2897-1
Alternate JournalEur J Nucl Med Mol Imaging
PubMed ID25331458
PubMed Central IDPMC4415610
Grant List2R01AG013616-22 / AG / NIA NIH HHS / United States
R01 HL111724 / HL / NHLBI NIH HHS / United States
R01 AG035137 / AG / NIA NIH HHS / United States
R01 AG013616 / AG / NIA NIH HHS / United States
P30 AG008051 / AG / NIA NIH HHS / United States
RC2 AG036502 / AG / NIA NIH HHS / United States
HL111724-01 / HL / NHLBI NIH HHS / United States
RC2-AG036502 / AG / NIA NIH HHS / United States
R01-AG035137 / AG / NIA NIH HHS / United States
Related Institute: 
Brain Health Imaging Institute (BHII)

Weill Cornell Medicine
Department of Radiology
525 East 68th Street New York, NY 10065